These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9844536)

  • 1. [Good clinical use of serum tumor markers].
    Boussen H; el May M; Jerbi G; Rahal K; Benna F; Mtimet S; Ben Ayed F
    Tunis Med; 1998 Feb; 76(2):1020-6. PubMed ID: 9844536
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum tumour markers in clinical practice. Some general aspects.
    Kvinnsland S
    Scand J Clin Lab Invest Suppl; 1991; 206():6-11. PubMed ID: 1947761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tumor markers].
    Sirotteau JC
    Soins; 1990 Feb; (533):33-5. PubMed ID: 2321057
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum tumor markers in skeletal metastasis.
    Tsukushi S; Katagiri H; Kataoka T; Nishida Y; Ishiguro N
    Jpn J Clin Oncol; 2006 Jul; 36(7):439-44. PubMed ID: 16815865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introduction to tumor markers from A to Z.
    Plaut D
    MLO Med Lab Obs; 2004 Aug; 36(8):22, 26. PubMed ID: 15366364
    [No Abstract]   [Full Text] [Related]  

  • 6. [Criteria for using tumor markers. 2: Indications and interpretation].
    Fateh-Moghadam VA; Stieber P
    Fortschr Med; 1996 Mar; 114(7):38-40. PubMed ID: 8900968
    [No Abstract]   [Full Text] [Related]  

  • 7. Combined detection of serum tumor markers for differential diagnosis of solid lesions located at the pancreatic head.
    Liao Q; Zhao YP; Yang YC; Li LJ; Long X; Han SM
    Hepatobiliary Pancreat Dis Int; 2007 Dec; 6(6):641-5. PubMed ID: 18086633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Usefulness of CEA, CA 15-3 and CA 125 tumor markers in the differential diagnostics of peritoneal effusion].
    Kiluk MS; Rółkowski R; Zawadzki RJ; Wojtukiewicz MZ
    Pol Merkur Lekarski; 2002 Oct; 13(76):298-301. PubMed ID: 12557435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers for cancer risk, early detection, and prognosis: the validation conundrum.
    Brenner DE; Normolle DP
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1918-20. PubMed ID: 17932336
    [No Abstract]   [Full Text] [Related]  

  • 10. Testing for anti-p53 antibodies increases the diagnostic sensitivity of conventional tumor markers.
    Müller M; Meyer M; Schilling T; Ulsperger E; Lehnert T; Zentgraf H; Stremmel W; Volkmann M; Galle PR
    Int J Oncol; 2006 Oct; 29(4):973-80. PubMed ID: 16964393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of common seric tumor markers in patients with solid cancers.
    Gara S; Boussen H; Ghanem A; Guemira F
    Tunis Med; 2008 Jun; 86(6):579-83. PubMed ID: 19216452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment monitoring, recurrence detection, prognosis. Here's where tumor markers make good sense].
    Lamerz R; Stieber P
    MMW Fortschr Med; 2002 Oct; 144(41):26-8, 30-2. PubMed ID: 12474357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum alpha one antitrypsin in malignancy.
    Yemul VL; Kumthekar SN; Muley PR; Agrawal BR
    Indian J Cancer; 1987 Jun; 24(2):107-11. PubMed ID: 3500907
    [No Abstract]   [Full Text] [Related]  

  • 14. Estimation of tumor necrosis factor-alpha in the diagnosis, the prognosis and the treatment follow-up of oral squamous cell carcinoma.
    Kurokawa H; Yamashita M; Yamashita Y; Murata T; Miura K; Kajiyama M
    Fukuoka Igaku Zasshi; 1998 Nov; 89(11):312-20. PubMed ID: 9884462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Extracellular DNA in plasma--a potential diagnostic marker in oncology].
    Gaziev AI; Shaĭhaev GO; Korenev SV
    Vopr Onkol; 2008; 54(5):545-54. PubMed ID: 19069466
    [No Abstract]   [Full Text] [Related]  

  • 16. [Study of serum levels of magnesium in the patients with malignant tumors].
    Varazashvili Varazi LM; Osmanova VR; Barkadze KI
    Georgian Med News; 2006 Jul; (136):35-9. PubMed ID: 16905841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical value of combined detection of serum tumor markers in lung cancer diagnosis].
    Chen F; Li WM; Wang DM; Gao SS; Bao Y; Chen WB; Liu D
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):832-5. PubMed ID: 19024326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tumor markers: theory or reality?].
    Molina R; Filella X; Ballesta AM
    Med Clin (Barc); 1994 Feb; 102(5):189-95. PubMed ID: 8127170
    [No Abstract]   [Full Text] [Related]  

  • 19. [Tumor markers in breast cancer].
    Kurebayashi J
    Gan To Kagaku Ryoho; 2004 Nov; 31(12):2077-81. PubMed ID: 15570944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous inappropriate use of serum tumour markers.
    Tran HA
    Intern Med J; 2005 Oct; 35(10):640-1; author reply 641. PubMed ID: 16207270
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.